Evidence map›Paper›PMID 40465182›Full record

ArticleInternational journal of clinical pharmacy2025

Evaluating a pharmacist-led cardio-renal-metabolic service to reduce healthcare inequities in a socioeconomically deprived population: a prospective intervention study.

Tania Ramos, Amit Verma, Iain Speirits, Ling Zhang, Janice McInally, Catherine McShane, Brian Kennon, Paul Forsyth, Richard Lowrie, Chris F Johnson

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Cardiovascular-Kidney-Metabolic Syndrome: Models of Care.Reviews in cardiovascular medicine · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tania RamosPharmacy Services, Glasgow City Health and Social Care Partnership (North East Locality), NHS Greater Glasgow and Clyde, Glasgow, G69 6GA, UK. tania.ramos2@nhs.scot.ORCID http://orcid.org/0009-0002-8055-6502
Amit VermaParade Group Practice, Townhead Health Centre, 16 Alexandra Parade, Glasgow, G31 2ES, UK.
Iain SpeiritsPharmacy Services, NHS Greater Glasgow and Clyde, Clarkston Ct, 56 Busby Rd, Glasgow, G76 7AT, UK.ORCID http://orcid.org/0000-0001-6606-809X
Ling ZhangTownhead Medical Practice, Townhead Health Centre, 16 Alexandra Parade, Glasgow, G31 2ES, UK.
Janice McInallyTownhead Medical Practice, Townhead Health Centre, 16 Alexandra Parade, Glasgow, G31 2ES, UK.
Catherine McShaneParade Group Practice, Townhead Health Centre, 16 Alexandra Parade, Glasgow, G31 2ES, UK.
Brian KennonQueen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF, UK.ORCID http://orcid.org/0000-0002-4963-5870
Paul ForsythPharmacy Services, NHS Greater Glasgow and Clyde, Clarkston Ct, 56 Busby Rd, Glasgow, G76 7AT, UK.ORCID http://orcid.org/0000-0003-3804-6795
Richard LowriePharmacy Services, NHS Greater Glasgow and Clyde, Clarkston Ct, 56 Busby Rd, Glasgow, G76 7AT, UK.
Chris F JohnsonPharmacy Services, NHS Greater Glasgow and Clyde, Clarkston Ct, 56 Busby Rd, Glasgow, G76 7AT, UK.ORCID http://orcid.org/0000-0002-6006-6605

Funding

NHS Greater Glasgow and Clyde Pharmacy Services Research Catalytic Funding Challenge Award Number 9
6 · The paper itself

Abstract

backgroundChronic kidney disease (CKD) is a leading cause of premature mortality, often coexisting with cardiovascular disease and diabetes mellitus; disproportionately affecting socioeconomically deprived groups. CKD is projected to increase due to ageing, obesity and diabetes. General practice clinical pharmacists (GPCPs) have been shown to be effective in challenging chronic disease prescribing. GPCP services for CKD remains underexplored.

aimThis study aimed to scope the potential of a GPCP-led intervention to optimise cardio-renal and metabolic risk factors in CKD stages 3-4.

methodAdults with CKD stages 3-4 from two urban, socioeconomically deprived general practices in NHS Greater Glasgow and Clyde in UK, were identified via practice records and GP referrals. Eligible patients were invited to attend a GPCP-led clinic (Nov 2021-Jan 2024), that included CKD monitoring (primary measure), patient education, life-style advice and medicines optimisation. Anonymised pre- and post-intervention data were analysed.

resultsIn total, 253 participants (median age 77, range 26-99) met inclusion criteria; 62% lived in the most deprived areas of Scotland; 62% were female. Of the 163 (64%) attending. eGFR increased by a mean of 2.9 (95% CI 1.41-4.40, P < 0.001) ml/min/1.73 m

conclusionAn integrated pharmacist-led, general practice-based cardio-renal and metabolic clinic, improved key CKD-related outcomes in deprived population. Further studies are needed to confirm long-term impact.

Indexed as

Cardiovascular DiseasesHealthcare DisparitiesPharmacistsRenal Insufficiency, ChronicAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedProfessional RoleProspective StudiesScotlandSocioeconomic FactorsCardio-renal syndromeGeneral practiceMetabolic diseasePharmacistPolypharmacyPrimary healthcare

Identifiers

PMID40465182

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.